Lynn Seely
Insider Reports History
- Location
- San Francisco, CA
- Signature
- /s/ Mark Meltz, Attorney-in-Fact
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Lynn Seely:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lyell Immunopharma, Inc. | President and CEO, Director | Common Stock | 74,266 | $1,737,081 | $23.39 | 11 Feb 2026 | Direct |
| Blueprint Medicines Corp | Director | Common Stock | 0 | $0 | $128.18 | 17 Jul 2025 | Direct |
| Lyell Immunopharma, Inc. | President and CEO, Director | Option (right to buy) | 155,000 | 10 Feb 2026 | Direct | ||
| Blueprint Medicines Corp | Director | Stock Option (Right to Buy) | 0 | 17 Jul 2025 | Direct |
Insider Reports Filed by Lynn Seely
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LYEL | Lyell Immunopharma, Inc. | 11 Feb 2026 | 1 | -$174,372 | 4 | President and CEO, Director | 12 Feb 2026, 20:47 |
| LYEL | Lyell Immunopharma, Inc. | 09 Feb 2026 | 3 | -$10,127 | 4 | President and CEO, Director | 11 Feb 2026, 21:03 |
| LYEL | Lyell Immunopharma, Inc. | 10 Nov 2025 | 1 | -$6,637 | 4 | President and CEO, Director | 12 Nov 2025, 20:36 |
| LYEL | Lyell Immunopharma, Inc. | 27 Oct 2025 | 1 | $0 | 4 | President and CEO, Director | 29 Oct 2025, 17:40 |
| LYEL | Lyell Immunopharma, Inc. | 20 Aug 2025 | 2 | -$76,518 | 4 | President and CEO, Director | 22 Aug 2025, 16:07 |
| LYEL | Lyell Immunopharma, Inc. | 11 Aug 2025 | 2 | -$8,313 | 4 | President and CEO, Director | 13 Aug 2025, 21:10 |
| BPMC | Blueprint Medicines Corp | 17 Jul 2025 | 12 | $0 | 4 | Director | 21 Jul 2025, 19:48 |
| BPMC | Blueprint Medicines Corp | 18 Jun 2025 | 1 | +$499,924 | 4 | Director | 24 Jun 2025, 16:25 |
| LYEL | Lyell Immunopharma, Inc. | 14 Mar 2025 | 1 | +$106,190 | 4 | President and CEO, Director | 18 Mar 2025, 18:59 |
| LYEL | Lyell Immunopharma, Inc. | 10 Feb 2025 | 3 | $0 | 4 | President and CEO, Director | 26 Feb 2025, 19:33 |
| BPMC | Blueprint Medicines Corp | 12 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 17:35 |
| LYEL | Lyell Immunopharma, Inc. | 09 Feb 2024 | 1 | $0 | 4 | President and CEO, Director | 13 Feb 2024, 20:17 |
| LYEL | Lyell Immunopharma, Inc. | 16 Nov 2023 | 2 | $0 | 4 | President and CEO, Director | 20 Nov 2023, 20:53 |
| BPMC | Blueprint Medicines Corp | 21 Jun 2023 | 2 | $0 | 4 | Director | 23 Jun 2023, 19:06 |
| LYEL | Lyell Immunopharma, Inc. | 15 Dec 2022 | 1 | $0 | 4 | President and CEO, Director | 19 Dec 2022, 15:20 |
| BPMC | Blueprint Medicines Corp | 21 Jun 2022 | 2 | $0 | 4 | Director | 30 Jun 2022, 21:52 |
| LYEL | Lyell Immunopharma, Inc. | 08 Jun 2022 | 1 | $0 | 4 | Director | 10 Jun 2022, 16:16 |
| LYEL | Lyell Immunopharma, Inc. | 16 Jun 2021 | 0 | $0 | 3 | Director | 16 Jun 2021, 19:23 |
| BPMC | Blueprint Medicines Corp | 02 Jun 2021 | 2 | $0 | 4 | Director | 04 Jun 2021, 16:16 |